NCT01248403View on ClinicalTrials.gov

A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior Chemotherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

July 31, 2017

Study Completion Date

October 31, 2019

Conditions
Advanced Gastric CancerEsophagogastric Junction Cancer
Interventions
DRUG

Paclitaxel

Paclitaxel 80 mg/m2 on day 1, day 8 and day 15 of every 28-day cycle.

DRUG

RAD001

RAD001 10mg (2 x5 mg tablets / day) d1-d28

Trial Locations (1)

60488

Krankenhaus Nordwest, Frankfurt am Main

All Listed Sponsors
lead

Krankenhaus Nordwest

OTHER

NCT01248403 - A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior Chemotherapy | Biotech Hunter | Biotech Hunter